Prognosis
China’s CanSino Says European Vaccine Order Talks Are Underway
- CanSino deal would mark first inroad into advanced economies
- Chinese makers face concerns over lack of full data disclosure
This article is for subscribers only.
CanSino Biologics Inc. said it’s in talks with a number of European countries about orders for its Covid-19 vaccine, which if signed would mark the first recognition of Chinese drugmakers’ inoculations in the developed world amid concerns over their relative lack of data disclosure.
Three European Union member states have approached the Tianjin-based vaccine developer to discuss a possible purchase, according to Pierre Morgon, CanSino’s senior vice president in charge of its international business. Morgon declined to identify the three European countries.